- Investing Ideas
- /
- Global Pharmaceuticals & Biotech ROE over 20
Global Pharmaceuticals & Biotech ROE over 20
Results
21
0 new
Companies with Return on Equity over 20%
21 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
JNJ | US$161.39 | -2.1% | 2.9% | US$386.6b | US$171.32 | PE23.7x | E7.2% | 3.1% | ||
MRK | US$113.09 | -3.5% | 8.4% | US$290.8b | US$139.03 | PE20.9x | E14.4% | 2.7% | ||
ZTS | US$194.87 | 0.8% | 12.0% | US$86.8b | US$213.12 | PE37.7x | E10.2% | 0.9% | ||
IQV | US$236.23 | -3.4% | 19.5% | US$42.2b | US$276.77 | PE30.3x | E13.2% | 0% | ||
A | US$146.74 | 3.4% | 31.0% | US$40.1b | US$147.51 | PE29.8x | E3.7% | 0.6% | ||
WST | US$307.14 | -1.3% | -19.0% | US$22.0b | US$351.85 | PE42.4x | E12.2% | 0.3% | ||
WAT | US$355.68 | 5.1% | 29.2% | US$20.2b | US$340.22 | PE35.4x | E8.2% | n/a | ||
MEDP | US$326.26 | -11.6% | 32.4% | US$9.9b | US$397.25 | PE29.7x | E13.5% | n/a | ||
CORT | US$43.28 | 5.8% | 31.2% | US$4.4b | US$65.40 | PE36.2x | E38.4% | n/a | ||
ALKS | US$27.17 | -4.2% | -3.5% | US$4.4b | US$34.69 | PE11.6x | E1.4% | n/a | ||
PTGX | US$44.93 | -2.2% | 162.3% | US$2.7b | US$52.13 | PE15.6x | E-34.9% | n/a | ||
AMPH | US$47.88 | -4.4% | 1.2% | US$2.3b | US$59.80 | PE14x | E14.1% | n/a | ||
HRMY | US$39.79 | 2.1% | 15.8% | US$2.1b | US$44.88 | PE19.7x | E34.5% | n/a | ||
PNT | US$12.50 | 0.2% | 75.1% | US$1.3b | US$12.50 | PE13.8x | E9.2% | n/a | ||
COLL | US$38.47 | -1.2% | 70.2% | US$1.2b | US$43.25 | PE12.4x | E18.8% | n/a | ||
INVA | US$18.94 | -3.7% | 43.2% | US$1.2b | US$18.00 | PE8.1x | S7.1% | 0% | ||
TRDA | US$15.77 | 5.1% | -2.5% | US$529.6m | US$23.90 | PE5.3x | E-57.0% | n/a | ||
ELTP | US$0.39 | 0.01% | 318.7% | US$414.5m | n/a | PE21.2x | n/a | n/a | ||
BSEM | US$10.35 | 3.1% | 305.9% | US$171.6m | US$24.25 | PE20.8x | S48.8% | n/a | ||
SPRO | US$1.28 | -5.5% | 6.7% | US$69.2m | US$7.50 | PE4x | E20.3% | n/a | ||
DTIL | US$9.11 | -3.8% | -14.7% | US$66.0m | US$33.60 | PE4.2x | E-43.7% | n/a |
Page 1 of 1